Holsboer F - Search Results

1

Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients.

Wetzel H, Wiedemann K, Holsboer F, Benkert O. Wetzel H, et al. Among authors: holsboer f. Psychopharmacology (Berl). 1991;103(2):280-3. doi: 10.1007/BF02244218. Psychopharmacology (Berl). 1991. PMID: 1674161

2

Open clinical trial on the sigma ligand panamesine in patients with schizophrenia.

Frieboes RM, Murck H, Wiedemann K, Holsboer F, Steiger A. Frieboes RM, et al. Among authors: holsboer f. Psychopharmacology (Berl). 1997 Jul;132(1):82-8. doi: 10.1007/s002130050323. Psychopharmacology (Berl). 1997. PMID: 9272763 Clinical Trial.

3

[Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].

Wetzel H, von Bardeleben U, Holsboer F, Benkert O. Wetzel H, et al. Among authors: holsboer f. Fortschr Neurol Psychiatr. 1991 Sep;59 Suppl 1:23-9. doi: 10.1055/s-2007-1000731. Fortschr Neurol Psychiatr. 1991. PMID: 1683336 Clinical Trial. German.

4

Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.

von Bardeleben U, Holsboer F, Gerken A, Benkert O. von Bardeleben U, et al. Among authors: holsboer f. Int Clin Psychopharmacol. 1989 Jan;4 Suppl 1:31-5. Int Clin Psychopharmacol. 1989. PMID: 2644337 Clinical Trial.

5

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.

Steiger A, Gerken A, Benkert O, Holsboer F. Steiger A, et al. Among authors: holsboer f. Eur Neuropsychopharmacol. 1993 Jun;3(2):117-26. doi: 10.1016/0924-977x(93)90263-l. Eur Neuropsychopharmacol. 1993. PMID: 8364347 Clinical Trial.

6

Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.

Garcia-Borreguero D, Lauer CJ, Ozdaglar A, Wiedemann K, Holsboer F, Krieg JC. Garcia-Borreguero D, et al. Among authors: holsboer f. Pharmacopsychiatry. 1992 Nov;25(6):261-4. doi: 10.1055/s-2007-1014418. Pharmacopsychiatry. 1992. PMID: 1494591

7

B-HT 920--a novel dopamine autoreceptor agonist in the treatment of patients with schizophrenia.

Wiedemann K, Benkert O, Holsboer F. Wiedemann K, et al. Among authors: holsboer f. Pharmacopsychiatry. 1990 Jan;23(1):50-5. doi: 10.1055/s-2007-1014482. Pharmacopsychiatry. 1990. PMID: 1969167

8

Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.

Schlegel S, von Bardeleben U, Wiedemann K, Frommberger U, Holsboer F. Schlegel S, et al. Among authors: holsboer f. Psychoneuroendocrinology. 1989;14(3):209-16. doi: 10.1016/0306-4530(89)90019-x. Psychoneuroendocrinology. 1989. PMID: 2756074

9

Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug.

von Bardeleben U, Benkert O, Holsboer F. von Bardeleben U, et al. Among authors: holsboer f. Pharmacopsychiatry. 1987 Feb;20(1 Spec No):28-34. doi: 10.1055/s-2007-1017126. Pharmacopsychiatry. 1987. PMID: 2883678

10

Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression.

Steiger A, Holsboer F, Gerken A, Demisch L, Benkert O. Steiger A, et al. Among authors: holsboer f. Pharmacopsychiatry. 1987 Nov;20(6):262-9. doi: 10.1055/s-2007-1017119. Pharmacopsychiatry. 1987. PMID: 3432361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters